Physician profile
Bryce W Murray
NPI 1871615757
$151,755.22
in general payments reported to CMS, 2019-2025
29 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $16K · 2021: $39K · 2022: $7,705 · 2023: $25K · 2024: $1,050 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $36K · Travel and Lodging: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,475 · Food and Beverage: $2,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $35,850.00 |
| Travel and Lodging | $10,391.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,475.00 |
| Food and Beverage | $2,937.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $138,236.33 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Ethicon INC. | $9,877.96 | 2020 | |
| Boston Scientific Corporation | $1,200.49 | 2019-2020 | |
| Medtronic USA, INC. | $302.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $298.81 | 2020-2025 | Gattex |
| Kci USA, INC. | $250.00 | 2022 | |
| Medtronic, INC. | $224.25 | 2022-2025 | Interstim |
| Axonics, INC. | $150.03 | 2023 | Axonics |
| Davol INC. | $146.00 | 2020-2023 | Arista Ah Flexitip |
| Coloplast Corp | $141.20 | 2021 | |
| Allergan, INC. | $127.18 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $122.99 | 2025 | |
| Ferring Pharmaceuticals INC. | $111.16 | 2019-2020 | |
| Baudax Bio INC. | $68.61 | 2021 | |
| Abbvie INC. | $64.56 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $59.00 | 2025 | Novosorb Btm |
| Biom'Up France Sas | $47.92 | 2020 | |
| Cook Medical LLC | $46.74 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $37.83 | 2019-2021 | |
| Shire North American Group INC | $35.19 | 2019 | |
| Curium US LLC | $32.76 | 2020 | |
| Merck Sharp & Dohme LLC | $30.44 | 2019-2020 | |
| Conmed Corporation | $24.66 | 2025 | Airseal |
| Acera Surgical, INC. | $24.39 | 2024 | Restrata Wound Matrix |
| Trevena, INC. | $23.23 | 2021 | |
| W. L. Gore & Associates, INC. | $19.31 | 2023 | Gore Synecor Biomaterial |
| Redhill Biopharma INC. | $19.17 | 2021 | |
| Apollo Endosurgery US INC | $18.51 | 2019 | |
| Myriad Genetic Laboratories, INC. | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.